FIRST REPORT OF THE REAL‐LIFE PROSPECTIVE OBSERVATIONAL STUDY “CAR‐T CELL IN DIFFUSE LARGE B‐CELL AND PRIMARY MEDIASTINAL LYMPHOMAS” OF THE ITALIAN SOCIETY OF HEMATOLOGY

Introduction: Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are anti-CD19 chimeric antigen receptor T cells (CAR-T) that proved very effective in relapsed/refractory (R/R) diffuse large B-cell (DLBCL) and primary mediastinal B-cell lymphoma (PMBCL). to evaluate safety and efficacy of axi-cel and tisa-cel. Methods: The Italian Society of Hematology (SIE) is conducting a prospective observational trial aimed to: 1. register all...